nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Tamoxifen—pancreatic cancer	0.0694	0.24	CbGbCtD
Avanafil—CYP3A4—Erlotinib—pancreatic cancer	0.059	0.204	CbGbCtD
Avanafil—CYP3A4—Irinotecan—pancreatic cancer	0.0533	0.185	CbGbCtD
Avanafil—CYP3A4—Docetaxel—pancreatic cancer	0.0391	0.135	CbGbCtD
Avanafil—CYP3A4—Sunitinib—pancreatic cancer	0.0389	0.135	CbGbCtD
Avanafil—CYP3A4—Doxorubicin—pancreatic cancer	0.0291	0.101	CbGbCtD
Avanafil—Diarrhoea—Erlotinib—pancreatic cancer	0.00118	0.00166	CcSEcCtD
Avanafil—Oedema peripheral—Docetaxel—pancreatic cancer	0.00118	0.00166	CcSEcCtD
Avanafil—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00118	0.00166	CcSEcCtD
Avanafil—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00118	0.00166	CcSEcCtD
Avanafil—Urethral disorder—Docetaxel—pancreatic cancer	0.00118	0.00165	CcSEcCtD
Avanafil—Infection—Fluorouracil—pancreatic cancer	0.00117	0.00165	CcSEcCtD
Avanafil—Pain in extremity—Epirubicin—pancreatic cancer	0.00117	0.00164	CcSEcCtD
Avanafil—Skin disorder—Gemcitabine—pancreatic cancer	0.00117	0.00164	CcSEcCtD
Avanafil—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00116	0.00163	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—pancreatic cancer	0.00116	0.00163	CcSEcCtD
Avanafil—Dizziness—Tamoxifen—pancreatic cancer	0.00116	0.00162	CcSEcCtD
Avanafil—Tachycardia—Fluorouracil—pancreatic cancer	0.00115	0.00162	CcSEcCtD
Avanafil—Hypotension—Irinotecan—pancreatic cancer	0.00115	0.00162	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00115	0.00161	CcSEcCtD
Avanafil—Dizziness—Erlotinib—pancreatic cancer	0.00114	0.00161	CcSEcCtD
Avanafil—Hypotension—Gemcitabine—pancreatic cancer	0.00112	0.00158	CcSEcCtD
Avanafil—Eye disorder—Docetaxel—pancreatic cancer	0.00112	0.00158	CcSEcCtD
Avanafil—Insomnia—Irinotecan—pancreatic cancer	0.00111	0.00157	CcSEcCtD
Avanafil—Flushing—Docetaxel—pancreatic cancer	0.00111	0.00157	CcSEcCtD
Avanafil—Cardiac disorder—Docetaxel—pancreatic cancer	0.00111	0.00157	CcSEcCtD
Avanafil—Vomiting—Tamoxifen—pancreatic cancer	0.00111	0.00156	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00111	0.00156	CcSEcCtD
Avanafil—Hypotension—Fluorouracil—pancreatic cancer	0.0011	0.00155	CcSEcCtD
Avanafil—Rash—Tamoxifen—pancreatic cancer	0.0011	0.00155	CcSEcCtD
Avanafil—Dermatitis—Tamoxifen—pancreatic cancer	0.0011	0.00155	CcSEcCtD
Avanafil—Vomiting—Erlotinib—pancreatic cancer	0.0011	0.00155	CcSEcCtD
Avanafil—Somnolence—Irinotecan—pancreatic cancer	0.0011	0.00154	CcSEcCtD
Avanafil—Blood creatinine increased—Epirubicin—pancreatic cancer	0.0011	0.00154	CcSEcCtD
Avanafil—Headache—Tamoxifen—pancreatic cancer	0.00109	0.00154	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00109	0.00154	CcSEcCtD
Avanafil—Rash—Erlotinib—pancreatic cancer	0.00109	0.00153	CcSEcCtD
Avanafil—Dermatitis—Erlotinib—pancreatic cancer	0.00109	0.00153	CcSEcCtD
Avanafil—Angiopathy—Docetaxel—pancreatic cancer	0.00109	0.00153	CcSEcCtD
Avanafil—Insomnia—Gemcitabine—pancreatic cancer	0.00109	0.00153	CcSEcCtD
Avanafil—Dyspepsia—Irinotecan—pancreatic cancer	0.00109	0.00153	CcSEcCtD
Avanafil—Immune system disorder—Docetaxel—pancreatic cancer	0.00108	0.00152	CcSEcCtD
Avanafil—Headache—Erlotinib—pancreatic cancer	0.00108	0.00152	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—pancreatic cancer	0.00108	0.00152	CcSEcCtD
Avanafil—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00108	0.00152	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00108	0.00151	CcSEcCtD
Avanafil—Asthenia—Sunitinib—pancreatic cancer	0.00107	0.00151	CcSEcCtD
Avanafil—Insomnia—Fluorouracil—pancreatic cancer	0.00107	0.0015	CcSEcCtD
Avanafil—Somnolence—Gemcitabine—pancreatic cancer	0.00107	0.0015	CcSEcCtD
Avanafil—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00106	0.0015	CcSEcCtD
Avanafil—Fatigue—Irinotecan—pancreatic cancer	0.00106	0.00149	CcSEcCtD
Avanafil—Pruritus—Sunitinib—pancreatic cancer	0.00106	0.00149	CcSEcCtD
Avanafil—Breast disorder—Epirubicin—pancreatic cancer	0.00106	0.00149	CcSEcCtD
Avanafil—Constipation—Irinotecan—pancreatic cancer	0.00105	0.00148	CcSEcCtD
Avanafil—Mental disorder—Docetaxel—pancreatic cancer	0.00105	0.00148	CcSEcCtD
Avanafil—Somnolence—Fluorouracil—pancreatic cancer	0.00105	0.00148	CcSEcCtD
Avanafil—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00105	0.00147	CcSEcCtD
Avanafil—Malnutrition—Docetaxel—pancreatic cancer	0.00104	0.00147	CcSEcCtD
Avanafil—Dyspepsia—Fluorouracil—pancreatic cancer	0.00104	0.00146	CcSEcCtD
Avanafil—Nausea—Tamoxifen—pancreatic cancer	0.00104	0.00146	CcSEcCtD
Avanafil—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00104	0.00146	CcSEcCtD
Avanafil—Fatigue—Gemcitabine—pancreatic cancer	0.00104	0.00146	CcSEcCtD
Avanafil—Gastritis—Epirubicin—pancreatic cancer	0.00103	0.00146	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00103	0.00145	CcSEcCtD
Avanafil—Constipation—Gemcitabine—pancreatic cancer	0.00103	0.00144	CcSEcCtD
Avanafil—Nausea—Erlotinib—pancreatic cancer	0.00103	0.00144	CcSEcCtD
Avanafil—Diarrhoea—Sunitinib—pancreatic cancer	0.00102	0.00144	CcSEcCtD
Avanafil—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00102	0.00143	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00101	0.00143	CcSEcCtD
Avanafil—Influenza—Epirubicin—pancreatic cancer	0.00101	0.00142	CcSEcCtD
Avanafil—Back pain—Docetaxel—pancreatic cancer	0.00101	0.00142	CcSEcCtD
Avanafil—Muscle spasms—Docetaxel—pancreatic cancer	0.001	0.00141	CcSEcCtD
Avanafil—Dizziness—Sunitinib—pancreatic cancer	0.00099	0.00139	CcSEcCtD
Avanafil—Angina pectoris—Epirubicin—pancreatic cancer	0.000984	0.00138	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—pancreatic cancer	0.000978	0.00137	CcSEcCtD
Avanafil—Body temperature increased—Irinotecan—pancreatic cancer	0.000974	0.00137	CcSEcCtD
Avanafil—Bronchitis—Epirubicin—pancreatic cancer	0.000972	0.00137	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000968	0.00136	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—pancreatic cancer	0.000958	0.00135	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000954	0.00134	CcSEcCtD
Avanafil—Vomiting—Sunitinib—pancreatic cancer	0.000951	0.00134	CcSEcCtD
Avanafil—Body temperature increased—Gemcitabine—pancreatic cancer	0.000949	0.00133	CcSEcCtD
Avanafil—Rash—Sunitinib—pancreatic cancer	0.000944	0.00133	CcSEcCtD
Avanafil—Dermatitis—Sunitinib—pancreatic cancer	0.000943	0.00133	CcSEcCtD
Avanafil—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000939	0.00132	CcSEcCtD
Avanafil—Headache—Sunitinib—pancreatic cancer	0.000937	0.00132	CcSEcCtD
Avanafil—Influenza—Doxorubicin—pancreatic cancer	0.000935	0.00132	CcSEcCtD
Avanafil—Pollakiuria—Epirubicin—pancreatic cancer	0.000934	0.00131	CcSEcCtD
Avanafil—Body temperature increased—Fluorouracil—pancreatic cancer	0.000933	0.00131	CcSEcCtD
Avanafil—Palpitations—Docetaxel—pancreatic cancer	0.000923	0.0013	CcSEcCtD
Avanafil—Weight increased—Epirubicin—pancreatic cancer	0.00092	0.00129	CcSEcCtD
Avanafil—Cough—Docetaxel—pancreatic cancer	0.000911	0.00128	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—pancreatic cancer	0.000911	0.00128	CcSEcCtD
Avanafil—Hypertension—Docetaxel—pancreatic cancer	0.000901	0.00127	CcSEcCtD
Avanafil—Infestation NOS—Epirubicin—pancreatic cancer	0.000901	0.00127	CcSEcCtD
Avanafil—Infestation—Epirubicin—pancreatic cancer	0.000901	0.00127	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—pancreatic cancer	0.000899	0.00126	CcSEcCtD
Avanafil—Chest pain—Docetaxel—pancreatic cancer	0.000889	0.00125	CcSEcCtD
Avanafil—Arthralgia—Docetaxel—pancreatic cancer	0.000889	0.00125	CcSEcCtD
Avanafil—Myalgia—Docetaxel—pancreatic cancer	0.000889	0.00125	CcSEcCtD
Avanafil—Nausea—Sunitinib—pancreatic cancer	0.000889	0.00125	CcSEcCtD
Avanafil—Asthenia—Irinotecan—pancreatic cancer	0.000884	0.00124	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000883	0.00124	CcSEcCtD
Avanafil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000876	0.00123	CcSEcCtD
Avanafil—Dry mouth—Docetaxel—pancreatic cancer	0.000869	0.00122	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000869	0.00122	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—pancreatic cancer	0.000864	0.00121	CcSEcCtD
Avanafil—Asthenia—Gemcitabine—pancreatic cancer	0.000861	0.00121	CcSEcCtD
Avanafil—Haematuria—Epirubicin—pancreatic cancer	0.000859	0.00121	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—pancreatic cancer	0.000851	0.0012	CcSEcCtD
Avanafil—Epistaxis—Epirubicin—pancreatic cancer	0.00085	0.0012	CcSEcCtD
Avanafil—Pruritus—Gemcitabine—pancreatic cancer	0.000849	0.00119	CcSEcCtD
Avanafil—Infection—Docetaxel—pancreatic cancer	0.000847	0.00119	CcSEcCtD
Avanafil—Sinusitis—Epirubicin—pancreatic cancer	0.000845	0.00119	CcSEcCtD
Avanafil—Diarrhoea—Irinotecan—pancreatic cancer	0.000843	0.00119	CcSEcCtD
Avanafil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000836	0.00118	CcSEcCtD
Avanafil—Pruritus—Fluorouracil—pancreatic cancer	0.000835	0.00117	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—pancreatic cancer	0.000834	0.00117	CcSEcCtD
Avanafil—Infestation—Doxorubicin—pancreatic cancer	0.000834	0.00117	CcSEcCtD
Avanafil—Tachycardia—Docetaxel—pancreatic cancer	0.000832	0.00117	CcSEcCtD
Avanafil—Skin disorder—Docetaxel—pancreatic cancer	0.000828	0.00116	CcSEcCtD
Avanafil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000822	0.00116	CcSEcCtD
Avanafil—Dizziness—Irinotecan—pancreatic cancer	0.000815	0.00115	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00081	0.00114	CcSEcCtD
Avanafil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000808	0.00114	CcSEcCtD
Avanafil—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000799	0.00112	CcSEcCtD
Avanafil—Oedema peripheral—Epirubicin—pancreatic cancer	0.000797	0.00112	CcSEcCtD
Avanafil—Hypotension—Docetaxel—pancreatic cancer	0.000796	0.00112	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—pancreatic cancer	0.000795	0.00112	CcSEcCtD
Avanafil—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000795	0.00112	CcSEcCtD
Avanafil—Urethral disorder—Epirubicin—pancreatic cancer	0.000793	0.00112	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—pancreatic cancer	0.000786	0.00111	CcSEcCtD
Avanafil—Vomiting—Irinotecan—pancreatic cancer	0.000784	0.0011	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—pancreatic cancer	0.000782	0.0011	CcSEcCtD
Avanafil—Dizziness—Fluorouracil—pancreatic cancer	0.000781	0.0011	CcSEcCtD
Avanafil—Rash—Irinotecan—pancreatic cancer	0.000777	0.00109	CcSEcCtD
Avanafil—Dermatitis—Irinotecan—pancreatic cancer	0.000776	0.00109	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000776	0.00109	CcSEcCtD
Avanafil—Headache—Irinotecan—pancreatic cancer	0.000772	0.00109	CcSEcCtD
Avanafil—Insomnia—Docetaxel—pancreatic cancer	0.000771	0.00108	CcSEcCtD
Avanafil—Vomiting—Gemcitabine—pancreatic cancer	0.000763	0.00107	CcSEcCtD
Avanafil—Somnolence—Docetaxel—pancreatic cancer	0.000758	0.00107	CcSEcCtD
Avanafil—Rash—Gemcitabine—pancreatic cancer	0.000757	0.00106	CcSEcCtD
Avanafil—Dermatitis—Gemcitabine—pancreatic cancer	0.000756	0.00106	CcSEcCtD
Avanafil—Eye disorder—Epirubicin—pancreatic cancer	0.000756	0.00106	CcSEcCtD
Avanafil—Headache—Gemcitabine—pancreatic cancer	0.000752	0.00106	CcSEcCtD
Avanafil—Flushing—Epirubicin—pancreatic cancer	0.000751	0.00106	CcSEcCtD
Avanafil—Cardiac disorder—Epirubicin—pancreatic cancer	0.000751	0.00106	CcSEcCtD
Avanafil—Vomiting—Fluorouracil—pancreatic cancer	0.000751	0.00106	CcSEcCtD
Avanafil—Dyspepsia—Docetaxel—pancreatic cancer	0.00075	0.00105	CcSEcCtD
Avanafil—Rash—Fluorouracil—pancreatic cancer	0.000744	0.00105	CcSEcCtD
Avanafil—Dermatitis—Fluorouracil—pancreatic cancer	0.000744	0.00105	CcSEcCtD
Avanafil—Headache—Fluorouracil—pancreatic cancer	0.00074	0.00104	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000739	0.00104	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000737	0.00104	CcSEcCtD
Avanafil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000736	0.00103	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000736	0.00103	CcSEcCtD
Avanafil—Fatigue—Docetaxel—pancreatic cancer	0.000735	0.00103	CcSEcCtD
Avanafil—Angiopathy—Epirubicin—pancreatic cancer	0.000734	0.00103	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—pancreatic cancer	0.000734	0.00103	CcSEcCtD
Avanafil—Nausea—Irinotecan—pancreatic cancer	0.000732	0.00103	CcSEcCtD
Avanafil—Immune system disorder—Epirubicin—pancreatic cancer	0.000731	0.00103	CcSEcCtD
Avanafil—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000729	0.00103	CcSEcCtD
Avanafil—Constipation—Docetaxel—pancreatic cancer	0.000729	0.00102	CcSEcCtD
Avanafil—Nausea—Gemcitabine—pancreatic cancer	0.000713	0.001	CcSEcCtD
Avanafil—Mental disorder—Epirubicin—pancreatic cancer	0.000709	0.000997	CcSEcCtD
Avanafil—Malnutrition—Epirubicin—pancreatic cancer	0.000704	0.00099	CcSEcCtD
Avanafil—Nausea—Fluorouracil—pancreatic cancer	0.000701	0.000986	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—pancreatic cancer	0.0007	0.000984	CcSEcCtD
Avanafil—Flushing—Doxorubicin—pancreatic cancer	0.000695	0.000977	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000695	0.000977	CcSEcCtD
Avanafil—Back pain—Epirubicin—pancreatic cancer	0.000681	0.000958	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—pancreatic cancer	0.000679	0.000955	CcSEcCtD
Avanafil—Muscle spasms—Epirubicin—pancreatic cancer	0.000677	0.000952	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—pancreatic cancer	0.000676	0.000951	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000675	0.000949	CcSEcCtD
Avanafil—Body temperature increased—Docetaxel—pancreatic cancer	0.000674	0.000947	CcSEcCtD
Avanafil—Vision blurred—Epirubicin—pancreatic cancer	0.000664	0.000933	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—pancreatic cancer	0.000656	0.000922	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—pancreatic cancer	0.000652	0.000916	CcSEcCtD
Avanafil—Agitation—Epirubicin—pancreatic cancer	0.000647	0.00091	CcSEcCtD
Avanafil—Vertigo—Epirubicin—pancreatic cancer	0.000633	0.00089	CcSEcCtD
Avanafil—Back pain—Doxorubicin—pancreatic cancer	0.00063	0.000886	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—pancreatic cancer	0.000626	0.000881	CcSEcCtD
Avanafil—Palpitations—Epirubicin—pancreatic cancer	0.000622	0.000875	CcSEcCtD
Avanafil—Cough—Epirubicin—pancreatic cancer	0.000615	0.000864	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—pancreatic cancer	0.000614	0.000864	CcSEcCtD
Avanafil—Asthenia—Docetaxel—pancreatic cancer	0.000611	0.00086	CcSEcCtD
Avanafil—Hypertension—Epirubicin—pancreatic cancer	0.000608	0.000855	CcSEcCtD
Avanafil—Pruritus—Docetaxel—pancreatic cancer	0.000603	0.000848	CcSEcCtD
Avanafil—Arthralgia—Epirubicin—pancreatic cancer	0.0006	0.000843	CcSEcCtD
Avanafil—Myalgia—Epirubicin—pancreatic cancer	0.0006	0.000843	CcSEcCtD
Avanafil—Chest pain—Epirubicin—pancreatic cancer	0.0006	0.000843	CcSEcCtD
Avanafil—Agitation—Doxorubicin—pancreatic cancer	0.000599	0.000842	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000595	0.000837	CcSEcCtD
Avanafil—Dry mouth—Epirubicin—pancreatic cancer	0.000586	0.000825	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—pancreatic cancer	0.000585	0.000823	CcSEcCtD
Avanafil—Diarrhoea—Docetaxel—pancreatic cancer	0.000583	0.00082	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—pancreatic cancer	0.000576	0.00081	CcSEcCtD
Avanafil—Infection—Epirubicin—pancreatic cancer	0.000571	0.000803	CcSEcCtD
Avanafil—Cough—Doxorubicin—pancreatic cancer	0.000569	0.0008	CcSEcCtD
Avanafil—Nervous system disorder—Epirubicin—pancreatic cancer	0.000564	0.000793	CcSEcCtD
Avanafil—Dizziness—Docetaxel—pancreatic cancer	0.000563	0.000792	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—pancreatic cancer	0.000563	0.000791	CcSEcCtD
Avanafil—Tachycardia—Epirubicin—pancreatic cancer	0.000561	0.000789	CcSEcCtD
Avanafil—Skin disorder—Epirubicin—pancreatic cancer	0.000558	0.000785	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—pancreatic cancer	0.000555	0.00078	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—pancreatic cancer	0.000555	0.00078	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—pancreatic cancer	0.000555	0.00078	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000551	0.000775	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—pancreatic cancer	0.000543	0.000763	CcSEcCtD
Avanafil—Vomiting—Docetaxel—pancreatic cancer	0.000542	0.000762	CcSEcCtD
Avanafil—Rash—Docetaxel—pancreatic cancer	0.000537	0.000755	CcSEcCtD
Avanafil—Hypotension—Epirubicin—pancreatic cancer	0.000537	0.000755	CcSEcCtD
Avanafil—Dermatitis—Docetaxel—pancreatic cancer	0.000537	0.000755	CcSEcCtD
Avanafil—Headache—Docetaxel—pancreatic cancer	0.000534	0.000751	CcSEcCtD
Avanafil—Infection—Doxorubicin—pancreatic cancer	0.000528	0.000743	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000524	0.000736	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000522	0.000733	CcSEcCtD
Avanafil—Insomnia—Epirubicin—pancreatic cancer	0.00052	0.000731	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—pancreatic cancer	0.000519	0.00073	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—pancreatic cancer	0.000517	0.000726	CcSEcCtD
Avanafil—Somnolence—Epirubicin—pancreatic cancer	0.000511	0.000718	CcSEcCtD
Avanafil—Nausea—Docetaxel—pancreatic cancer	0.000506	0.000712	CcSEcCtD
Avanafil—Dyspepsia—Epirubicin—pancreatic cancer	0.000506	0.000711	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—pancreatic cancer	0.000497	0.000699	CcSEcCtD
Avanafil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000496	0.000698	CcSEcCtD
Avanafil—Fatigue—Epirubicin—pancreatic cancer	0.000496	0.000697	CcSEcCtD
Avanafil—Constipation—Epirubicin—pancreatic cancer	0.000491	0.000691	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000484	0.000681	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—pancreatic cancer	0.000481	0.000676	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—pancreatic cancer	0.000473	0.000665	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—pancreatic cancer	0.000468	0.000658	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000459	0.000646	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—pancreatic cancer	0.000458	0.000645	CcSEcCtD
Avanafil—Constipation—Doxorubicin—pancreatic cancer	0.000455	0.000639	CcSEcCtD
Avanafil—Body temperature increased—Epirubicin—pancreatic cancer	0.000454	0.000639	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—pancreatic cancer	0.00042	0.000591	CcSEcCtD
Avanafil—Asthenia—Epirubicin—pancreatic cancer	0.000412	0.00058	CcSEcCtD
Avanafil—Pruritus—Epirubicin—pancreatic cancer	0.000407	0.000572	CcSEcCtD
Avanafil—Diarrhoea—Epirubicin—pancreatic cancer	0.000393	0.000553	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—pancreatic cancer	0.000382	0.000537	CcSEcCtD
Avanafil—Dizziness—Epirubicin—pancreatic cancer	0.00038	0.000534	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—pancreatic cancer	0.000376	0.000529	CcSEcCtD
Avanafil—Vomiting—Epirubicin—pancreatic cancer	0.000365	0.000514	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000364	0.000512	CcSEcCtD
Avanafil—Rash—Epirubicin—pancreatic cancer	0.000362	0.00051	CcSEcCtD
Avanafil—Dermatitis—Epirubicin—pancreatic cancer	0.000362	0.000509	CcSEcCtD
Avanafil—Headache—Epirubicin—pancreatic cancer	0.00036	0.000506	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—pancreatic cancer	0.000352	0.000495	CcSEcCtD
Avanafil—Nausea—Epirubicin—pancreatic cancer	0.000341	0.00048	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—pancreatic cancer	0.000338	0.000475	CcSEcCtD
Avanafil—Rash—Doxorubicin—pancreatic cancer	0.000335	0.000472	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—pancreatic cancer	0.000335	0.000471	CcSEcCtD
Avanafil—Headache—Doxorubicin—pancreatic cancer	0.000333	0.000468	CcSEcCtD
Avanafil—Nausea—Doxorubicin—pancreatic cancer	0.000316	0.000444	CcSEcCtD
